GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like Adaptimmune's CMO Moves Forward with SPEAR T Cell Therapies January 9, 2018 Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff September 4, 2017 Xeris Raises $55M for Glucagon Rescue Pen March 8, 2018
Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff September 4, 2017
